At the Life Sciences Patents Network Europe 2016, a conference hosted in London by LSIPR, Thomas Kolzau of Enin Pharma led a roundtable on mature licensing strategies.
Kolzau explains: “Our company wants to license out substances for cancer therapy, as well as for second generation sequencing optimisation, and this of course needs licensing strategies.”
Enin Pharma, Thomas Kolzau, LSPN 2016, mature licensing, Europe, Video, interview
